Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Caredx Inc (CDNA)

Caredx Inc (CDNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 953,053
  • Shares Outstanding, K 51,433
  • Annual Sales, $ 333,790 K
  • Annual Income, $ 52,550 K
  • EBIT $ -46 M
  • EBITDA $ -26 M
  • 60-Month Beta 2.54
  • Price/Sales 2.99
  • Price/Cash Flow 14.27
  • Price/Book 3.21

Options Overview Details

View History
  • Implied Volatility 129.39% (+39.08%)
  • Historical Volatility 69.60%
  • IV Percentile 94%
  • IV Rank 58.36%
  • IV High 183.59% on 11/28/25
  • IV Low 53.41% on 05/21/25
  • Expected Move (DTE 12) 1.98 (10.69%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 11
  • Volume Avg (30-Day) 87
  • Put/Call OI Ratio 0.30
  • Today's Open Interest 2,285
  • Open Int (30-Day) 2,695
  • Expected Range 16.55 to 20.51

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.00
  • Number of Estimates 2
  • High Estimate 0.01
  • Low Estimate -0.01
  • Prior Year 1.51
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.58 +27.09%
on 11/06/25
19.80 -6.41%
on 12/04/25
+2.00 (+12.10%)
since 11/05/25
3-Month
13.12 +41.24%
on 09/10/25
19.80 -6.41%
on 12/04/25
+4.71 (+34.08%)
since 09/05/25
52-Week
10.96 +69.07%
on 07/17/25
25.95 -28.59%
on 01/14/25
-6.17 (-24.98%)
since 12/05/24

Most Recent Stories

More News
SHORE Study Demonstrates HeartCare's Prognostic Value for Heart Transplant Recipients, Published in Journal of Heart and Lung Transplantation

Third SHORE Publication Highlights HeartCare’s Role in Risk Stratification and Personalized Post-Transplant Care

CDNA : 18.53 (-4.53%)
CareDx to Participate in Upcoming Investor Conferences

CareDx, Inc. (Nasdaq: CDNA)- The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare...

CDNA : 18.53 (-4.53%)
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value...

CDNA : 18.53 (-4.53%)
CareDx Announces New Precision Kidney Transplant Data and Product Innovations at ASN Kidney Week 2025

CareDx Extends Leadership in Kidney Transplant Molecular Testing with Launch of Unique Tissue-Based Gene Expression Assay – HistoMap Kidney

CDNA : 18.53 (-4.53%)
CareDx: Q3 Earnings Snapshot

CareDx: Q3 Earnings Snapshot

CDNA : 18.53 (-4.53%)
CareDx Announces Third Quarter 2025 Financial Results

Total Revenue of $100 Million Increased 21% Year-Over-Year Grew Testing Services Volume to Approximately 50,300, Increase of 13% Year-Over-Year ...

CDNA : 18.53 (-4.53%)
CareDx Announces Appointment of Jeffrey John Teuteberg, MD as Chief Medical Officer

Renowned Transplant Clinician to Lead CareDx Global Medical Affairs

CDNA : 18.53 (-4.53%)
CareDx Announces Largest Landmark Study of Its Kind on Antibody Mediated Rejection in Heart Transplantation Published in Journal of the American College of Cardiology: Heart Failure

Second SHORE Study Validates AlloSure Heart, an Integral Component of HeartCare, as a Reliable Biomarker for Antibody-Mediated Rejection in Heart Transplant Recipients

CDNA : 18.53 (-4.53%)
CareDx Announces Appointment of Suresh Gunasekaran to Board of Directors

CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value diagnostic solutions for transplant...

CDNA : 18.53 (-4.53%)
CareDx to Report Third Quarter 2025 Financial Results on November 4, 2025

CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients...

CDNA : 18.53 (-4.53%)

Business Summary

CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of...

See More

Key Turning Points

3rd Resistance Point 20.11
2nd Resistance Point 19.73
1st Resistance Point 19.13
Last Price 18.53
1st Support Level 18.15
2nd Support Level 17.77
3rd Support Level 17.17

See More

52-Week High 25.95
Fibonacci 61.8% 20.22
Last Price 18.53
Fibonacci 50% 18.45
Fibonacci 38.2% 16.69
52-Week Low 10.96

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar